title: Effects of low-dose marine oils on intimal hyperplasia in autologous vein grafts.
abstract: The effects of low-dose cod-liver oil on intimal hyperplasia of vein grafts were examined in 45 adult mongrel dogs undergoing peripheral arterial reconstruction. Fifteen animals served as the control group, 15 animals were fed a fish-oil supplement containing 240 mg of eicosapentaenoic acid daily, and a further 15 animals received 480 mg of eicosapentaenoic acid daily. Segments of undistended external jugular vein were anastomosed to bilaterally divided femoral arteries. The grafts were harvested at 6 weeks and intimal thickness was measured with a computerized interactive image analyzing system. Serum cholesterol level, prothrombin time, partial thromboplastin time, bleeding time, and platelet counts were measured before the operation and at 2, 4, and 6 weeks after the operation. Plasma levels of thromboxane B2 and prostaglandin F1 alpha and serum levels of eicosapentaenoic acid were measured before and 4 weeks after the operation. Serum cholesterol level increased similarly and significantly in all animals. Serum levels of eicosapentaenoic acid rose proportionately with the oral ingestion of fish oil but did not affect coagulation parameters. Plasma thromboxane B2 and prostaglandin F1 alpha were not significantly affected by the ingestion of marine oils. Intimal thickness was 39 +/- 5 microns in the control dogs. Ingestion of 240 mg of eicosapentaenoic acid reduced intimal thickness to 24 +/- 3 microns at 6 weeks (p less than 0.01). Increasing the dose by a factor of 2 did not decrease intimal thickness further, the intima being 23 +/- 2 microns (p less than 0.005). Our data indicate that small doses of fish oil will reduce intimal proliferation in autologous vein grafts and that marine oils may exert their beneficial effects on intimal hyperplasia by a mechanism other than their known effects on prostanoid metabolism.
authors.affiliation: Dalhousie University, Department of Surgery, Halifax, Nova Scotia, Canada.
authors.forename: R W
authors.initials: RW
authors.lastname: Landymore
authors.forename: M S
authors.initials: MS
authors.lastname: Manku
authors.forename: M
authors.initials: M
authors.lastname: Tan
authors.forename: M A
authors.initials: MA
authors.lastname: MacAulay
authors.forename: B
authors.initials: B
authors.lastname: Sheridan
mesh_terms: D000818:Animals; D001807:Blood Vessel Prosthesis; D003060:Cod Liver Oil / Q000008:administration & dosage / Q000494:pharmacology*; D004285:Dogs; D015118:Eicosapentaenoic Acid / Q000097:blood; D005263:Femoral Artery / Q000601:surgery; D005395:Fish Oils / Q000494:pharmacology*; D006965:Hyperplasia; D007601:Jugular Veins / Q000637:transplantation*; D009131:Muscle, Smooth, Vascular / Q000473:pathology*; D011460:Prostaglandins F / Q000097:blood; D013929:Thromboxane B2 / Q000097:blood; D014182:Transplantation, Autologous
chemical_list: D005395:Fish Oils; D011460:Prostaglandins F; D013929:Thromboxane B2; D003060:Cod Liver Oil; D015118:Eicosapentaenoic Acid; C100006:prostaglandin F1